Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
3,148,485
-
Shares change
-
-1,595,843
-
Total reported value, excl. options
-
$22,473,059
-
Value change
-
-$10,316,735
-
Put/Call ratio
-
58.1%
-
Number of buys
-
22
-
Number of sells
-
-35
-
Price
-
$6.16
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q2 2021
66 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q2 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,148,485 shares
of 26,828,643 outstanding shares and own 11.74% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (861,540 shares), AWM Investment Company, Inc. (500,000 shares), BlackRock Inc. (301,058 shares), PRICE T ROWE ASSOCIATES INC /MD/ (217,782 shares), GEODE CAPITAL MANAGEMENT, LLC (155,281 shares), MILLENNIUM MANAGEMENT LLC (134,928 shares), Westside Investment Management, Inc. (101,800 shares), MARSHALL WACE, LLP (84,912 shares), STATE STREET CORP (83,772 shares), and Parametric Portfolio Associates LLC (78,542 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.